Keywords: Watson Pharma, Ranbaxy, Lipitor, Pfizer, Teva, Cholesterol lowerer, USA

Watson and Ranbaxy kick off genericization of Lipitor, launching their approved copies in USA

Article | 01 December 2011

Print This

US generic drug major Watson Pharmaceuticals (NYSE: WPI) was the first to confirm yesterday that it has launched an authorized ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in